Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. - Wikidata - awgldk - TriplyDB

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.

http://www.wikidata.org/entity/Q34337012

about

Erythropoietin or darbepoetin for patients with cancer Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data Erythropoietin for patients with malignant disease Erythropoietin or Darbepoetin for patients with cancer Erythropoietin, uncertainty principle and cancer related anaemia.Cytokine use and survival in the first-line treatment of ovarian cancer: a Gynecologic Oncology Group Study Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.Toxicities of the platinum antineoplastic agents.Hematology in palliative medicine.The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Pharmacotherapy of anaemia in cancer patients.Evaluation and management of anemia in the elderly The efficacy of rHuEPO in cancer-related anaemia.The war on cancer: a report from the front lines Evaluating the effectiveness of epoetin alfa in community oncology practices.Pharmacotherapy of chemotherapy-induced anaemia.Guidelines for the treatment of elderly cancer patients.The use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia.Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life.Correlation between hemoglobin and fatigue in women undergoing adjuvant chemotherapy without erythropoietin-stimulating-agent support Does recombinant human erythropoietin accelerate correction of post-ulcer-bleeding anaemia? A pilot study.Safety considerations for erythropoietin treatment in patients with cancer.Role of erythropoietin in cancer-related anaemia: a double-edged sword?Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia.Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated.Managing anemia in lymphoma and multiple myeloma Patterns of care in community-based oncology practices for anemia associated with myelosuppressive chemotherapy.Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.Darbepoetin alfa in anemia of myelodysplastic syndromes: present and beyond.Impact of erythropoiesis-stimulating agent prescribing at an Asian cancer center, after release of safety advisories.Cancer-related fatigue: a practical review.Erythropoiesis-stimulating agents in cancer patients: reflections on safety.(Meta)analyze this: Systematic reviews might lose credibility.Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis.Making personalized medicine more affordable.Two faces for Janus: recombinant human erythropoiesis-stimulating agents and cancer mortality.Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea.Costs of care for lung and colon cancer patients receiving chemotherapy following FDA policy changes.Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia.

P2860

Q24202335-39AC8AE6-3510-4B8A-BA45-B3FC99B43BC1 Q24240202-BF05A28F-7320-4024-8A13-8607D9241C8B Q24242864-4739435C-E73C-42D5-AFE6-F421DF613986 Q24245427-A79437DA-3CD4-4932-888A-589E7AF6EF30 Q24245464-3A8D84F4-4EE7-4B06-A088-BADF2DE20FAF Q24791480-B697A66D-4A04-4D3E-AA77-EB4D0DCF959B Q30416045-B8E4890B-1640-4712-9326-785DCBD07FDB Q33243661-390CB16B-88F6-40E3-A35B-AA8544E78E66 Q33357351-1C10A534-4D24-4B5C-91E4-978536F45102 Q33364223-1C3C40C7-A2C7-42D8-89F3-C05AD28D41EE Q34095827-86B50579-1FCA-48AB-AC1C-1598A3414B88 Q34515556-8FEB819D-4672-45E9-85B3-984534362314 Q34893552-C07047BB-6F8E-43A1-B4B7-705FB0233338 Q35096645-B05F555C-737B-4728-94EE-29507F03B4E7 Q35103643-30CE3777-4DFB-42CA-9858-DF27A5E1A5F5 Q35197156-0157E818-D44B-41AB-95A8-6AF1B2D158A9 Q35593977-128A0D1E-5032-4B1F-8F7F-23A559768061 Q35599058-1161AAAF-2D90-45DA-A370-EFB97D348604 Q36082066-B5FE4134-C39A-423B-B6D7-EC9B3D32774C Q36108562-F7B5253C-7C05-425D-A958-FEEF63B9CC0A Q36399133-F755ADFA-666F-4873-BFB9-F0BB8917898A Q36474318-59FA1FDA-7ABD-4D52-AB77-594F38104DB1 Q36689075-DBF0A7DB-D1C5-4F15-AE0E-D3ABC881845D Q37071262-0957B889-AF63-4591-9BE3-2FFF861D747C Q37109136-C2CFA100-C073-49A7-8F29-C10789E8B9B5 Q37145284-85F64106-D99E-491D-A457-A8903882C21B Q37252771-092B5CAE-9482-41AA-B62E-3C7AEF9843B0 Q37466470-15D20F4C-31F9-4C27-BBAF-3DC985E9A9D5 Q37564558-4A383418-3C32-4E86-B16F-8855A4A1BE70 Q37702223-F1993AD4-23C4-4993-92D0-394AC66C4F28 Q37775781-5ECE9348-43AB-4D1D-AFFA-6F5ED65C6966 Q37843136-7A2384C4-5318-4166-ABD3-01CBE5190840 Q37960528-7077712A-0E9D-453A-88FA-D085E0582DFF Q38041965-61F6FA24-7872-4F11-A166-FDB0AA9C9E95 Q38130141-39FD9CE7-5515-4C03-A195-82F3F24389AB Q38366494-89E64EC1-02F5-4B74-B0BD-08C63CD35C90 Q42480000-6DA2FBC5-5C09-4A68-B02A-F658BCEF6DB1 Q47582617-AE160BA1-62D5-4913-BC1C-90E57232C99F Q48277049-725A679A-F5F3-4392-AF71-D09A8196E640 Q50547672-6B8B133E-E913-4A3F-AD61-D50A031D4593

P2860

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.

http://www.wikidata.org/entity/Q34337012

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Epoetin treatment of anemia as ...... of controlled clinical trials.

@ast

Epoetin treatment of anemia as ...... of controlled clinical trials.

@en

Epoetin treatment of anemia as ...... of controlled clinical trials.

@nl

type

label

Epoetin treatment of anemia as ...... of controlled clinical trials.

@ast

Epoetin treatment of anemia as ...... of controlled clinical trials.

@en

Epoetin treatment of anemia as ...... of controlled clinical trials.

@nl

prefLabel

Epoetin treatment of anemia as ...... of controlled clinical trials.

@ast

Epoetin treatment of anemia as ...... of controlled clinical trials.

@en

Epoetin treatment of anemia as ...... of controlled clinical trials.

@nl

P1433

Q34337012-B16223F2-AFC2-4FE2-92CA-70702BD2EDC6

P1476

Q34337012-6E9CBAC0-A408-43B8-AC46-6AE117D79228

P2093

Q34337012-3141F519-1CD1-4251-9BB7-DAB6100255FA

Q34337012-451223B5-DA27-4A3F-BDA8-BC34A645E72B

Q34337012-500ED4C9-98B0-4B40-A97C-496D4530062A

Q34337012-51C85D34-6FD6-4C6B-B747-CCACC41D2691

Q34337012-545B45AE-9299-4D2F-9409-CE9C8492D9AA

Q34337012-7A165229-DF72-450A-AED2-3BFE5438FB97

Q34337012-7E37B575-D5BF-4259-9144-3F7551D3DE87

Q34337012-84A3174E-9295-4DFE-BC0B-9E871ED76120

Q34337012-DB44CA13-D854-47E0-9E72-3F4584A9C090

Q34337012-E382C129-61AC-4044-8CDA-47233AD255A4

P2860

Q34337012-0108AD80-48CD-4286-BAD9-4706A4BA9144

Q34337012-0BA00FAA-2C91-4B0F-8813-8897F3DABD42

Q34337012-0D2F33E1-AC9A-477E-B527-74E834C3EBB1

Q34337012-1B47E4D7-07D6-464B-9056-B45C030547CE

Q34337012-21FC57FA-2695-45E0-A145-EDC6E3DFF279

Q34337012-29DE5D61-7B32-4D5A-94B6-33E0BB1EA57F

Q34337012-301DCC2E-F4FA-486B-B810-2557E37FEAC6

Q34337012-314594E7-84E9-4AA9-9455-386D25E71787

Q34337012-337BAC26-0683-45CB-BC98-1982333C61A6

Q34337012-4B929981-E086-4745-BF0B-C971CEAB6051

P304

Q34337012-BBE65BBA-6C9A-4951-989C-EF587BA16899

P31

Q34337012-FFA1E8AD-7A8C-49BD-88B6-B59E71CAAE9F

Q34337012-ba7bfd46-1375-4a09-9444-45d81e7a998a

P356

Q34337012-B0B216B6-51CB-4724-A1F2-9AA1F8B7BB32

P407

Q34337012-5E133E65-1B9D-4A6D-9CBD-F59CA0AEC674

P433

Q34337012-EE2F7E2B-7C31-4B97-BA80-2F4B9D2B3FF5

P478

Q34337012-CF0C4E1A-0501-42B7-93C5-5652907A6BFB

P577

Q34337012-882BA0D5-467D-4A41-84B8-59A9E3EFD543

P5875

Q34337012-921468D9-8EBE-4DF0-894E-8E59B625D652

P698

Q34337012-86EE8AAC-75C1-479B-9983-1ABF5D7A4D44

P921

Q34337012-085EDF5A-9E0B-483F-8D94-9C1ABFF8C494

P356

P1433

Journal of the National Cancer Institute

P1476

Epoetin treatment of anemia as ...... of controlled clinical trials.

@en

P2093

Armitage JO

http://www.w3.org/2001/XMLSchema#string

Aronson N

http://www.w3.org/2001/XMLSchema#string

Bennett CL

http://www.w3.org/2001/XMLSchema#string

Flamm C

http://www.w3.org/2001/XMLSchema#string

Gordon MS

http://www.w3.org/2001/XMLSchema#string

Hasselblad V

http://www.w3.org/2001/XMLSchema#string

Lichtin AE

http://www.w3.org/2001/XMLSchema#string

Piper M

http://www.w3.org/2001/XMLSchema#string

Seidenfeld J

http://www.w3.org/2001/XMLSchema#string

Wade JL 3rd

http://www.w3.org/2001/XMLSchema#string

P2860

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Meta-analysis in clinical trials

An assessment of clinically useful measures of the consequences of treatment

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

The hazards of scoring the quality of clinical trials for meta-analysis

Chemotherapy-induced anemia in adults: incidence and treatment.

Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia.

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

P304

1204-1214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/93.16.1204

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11839815

http://www.w3.org/2001/XMLSchema#string

P698

11504766

http://www.w3.org/2001/XMLSchema#string

P921